Effect of aclidinium bromide on cough and sputum symptoms in moderate-to-severe COPD in three phase III trials

BACKGROUND: Cough and sputum are troublesome symptoms in chronic obstructive pulmonary disease (COPD) and are associated with adverse outcomes. The efficacy of aclidinium bromide 400 µg twice daily in patients with stable COPD has been established in two phase III studies (ACCORD COPD I and ATTAIN)...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMJ Open Respir Res
Main Authors: McGarvey, Lorcan, Morice, Alyn H, Smith, Jaclyn A, Birring, Surinder S, Chuecos, Ferran, Seoane, Beatriz, Jarreta, Diana
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2016
Assuntos:
Chronic Obstructive Pulmonary Disease
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5174811/
https://ncbi.nlm.nih.gov/pubmed/28074135
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjresp-2016-000148
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados